Toxicity and outcome with induction chemotherapy in patients with advanced head and neck cancer

Project: Research

Status	Finished
Effective start/end date	1/02/14 → 1/02/15

Clonal evolution and heterogeneity in metastatic head and neck cancer-An analysis of the Austrian Study Group of Medical Tumour Therapy study group
Melchardt, T. (First author), Magnes, T. (Co-author), Hufnagl, C. (Co-author), Thorner, A. R., Ducar, M., Neureiter, D. (Co-author), Tränkenschuh, W., Klieser, E. (Co-author), Gaggl, A. (Co-author), Rösch, S. (Co-author), Rasp, G. (Co-author), Hartmann, T. (Co-author), Pleyer, L. (Co-author), Rinnerthaler, G. (Co-author), Weiss, L. (Co-author), Greil, R. (Co-author) & Egle, A. (Last author), Apr 2018, In: EUROPEAN JOURNAL OF CANCER . 93, p. 69-78 10 p.
Research output: Contribution to journal › Original Article › peer-review
30 Citations (Web of Science)
CYP39A1 polymorphism is associated with toxicity during intensive induction chemotherapy in patients with advanced head and neck cancer
Melchardt, T. (First author), Hufnagl, C. (First author), Magnes, T. (Co-author), Weiss, L. (Co-author), Hutarew, G. (Co-author), Neureiter, D. (Co-author), Schlattau, A. (Co-author), Moser, G. (Co-author), Gaggl, A. (Co-author), Tränkenschuh, W. (Co-author), Greil, R. (Co-author) & Egle, A. (Last author), 16 Oct 2015, In: BMC CANCER. 15, p. 725
Research output: Contribution to journal › Original Article › peer-review
12 Citations (Web of Science)

Project Details